AI Science Tracker
EN

Beyond SOFA and APACHE II, Novel Risk Stratification Models Using Readily Available Biomarkers in Critical Care.

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea · 28 Apr 2025 · medicine

Discovery

Beyond SOFA and APACHE II, Novel Risk Stratification Models Using Readily Available Biomarkers in Critical Care.

Source check: Source checked. Not independent scientific confirmation.

Finding: A 19,720-patient ICU cohort produced a logistic risk model using biomarker ratios, ventilation and CRRT that internally discriminated in-hospital mortality (AUC 0.929), comparable to SOFA (0.931); the paper does not establish superiority or external generalization. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.

Technology: XGBoost/SHAP ranks predictors before logistic mortality models; the enabled outcome is ICU mortality risk stratification.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
XGBoost/SHAP ranks predictors before logistic mortality models; the enabled outcome is ICU mortality risk stratification.
Test and result
The primary Results report 666 deaths and Model 3 (LAR, NPAR, mechanical ventilation, CRRT) AUC 0.929 (95% CI 0.921–0.937); SOFA AUC 0.931 and DeLong p=0.052. This supports a bounded internally tested clinical prediction result, not claimed improvement over SOFA.
Limitation / still unknown
Primary Methods describe repeated 70/30 train/test splits; Results also report 10-fold internal cross-validation. No external cohort is reported, and the split descriptions are not fully consistent; conclusions are limited to internal retrospective performance.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/40361939 · https://pmc.ncbi.nlm.nih.gov/articles/PMC12071242/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.